Maxrets Ventures Past Earnings Performance

Past criteria checks 0/6

Maxrets Ventures has been growing earnings at an average annual rate of 14.5%, while the Pharmaceuticals industry saw earnings declining at 5.2% annually.

Key information

14.5%

Earnings growth rate

14.5%

EPS growth rate

Pharmaceuticals Industry Growth14.1%
Revenue growth raten/a
Return on equity-2,515.8%
Net Marginn/a
Last Earnings Update31 Oct 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Maxrets Ventures makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OFEX:MAX Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Oct 230000
31 Oct 220-110
31 Jul 220-110
30 Apr 220-110
31 Jan 220000
31 Oct 210000
30 Apr 210000
31 Jan 210000

Quality Earnings: MAX is currently unprofitable.

Growing Profit Margin: MAX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if MAX's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Unable to compare MAX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MAX is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (9.5%).


Return on Equity

High ROE: MAX has a negative Return on Equity (-2515.79%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 00:56
End of Day Share Price 2024/12/24 00:00
Earnings2023/10/31
Annual Earnings2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Maxrets Ventures Plc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution